MENU
+Compare
HLBBF
Stock ticker: OTC
AS OF
Aug 12 closing price
Price
$5.52
Change
+$0.37 (+7.18%)
Capitalization
5.86B

HLBBF H. Lundbeck A/S Forecast, Technical & Fundamental Analysis

Lundbeck is a Denmark-based pharmaceutical firm that focuses on the development and commercialization of central nervous system drugs including antidepressants, antipsychotics, and antiepileptic products... Show more

HLBBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for HLBBF with price predictions
Aug 15, 2025

HLBBF's RSI Indicator ascends from oversold territory

The RSI Oscillator for HLBBF moved out of oversold territory on August 12, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 11 similar instances when the indicator left oversold territory. In of the 11 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 08, 2025. You may want to consider a long position or call options on HLBBF as a result. In of 25 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for HLBBF just turned positive on August 12, 2025. Looking at past instances where HLBBF's MACD turned positive, the stock continued to rise in of 24 cases over the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

HLBBF moved below its 50-day moving average on July 21, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for HLBBF crossed bearishly below the 50-day moving average on July 25, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 8 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

HLBBF broke above its upper Bollinger Band on August 12, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for HLBBF entered a downward trend on August 15, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.441) is normal, around the industry mean (16.499). P/E Ratio (9.983) is within average values for comparable stocks, (72.127). Projected Growth (PEG Ratio) (7.604) is also within normal values, averaging (4.761). Dividend Yield (0.025) settles around the average of (0.031) among similar stocks. P/S Ratio (1.481) is also within normal values, averaging (40.137).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. HLBBF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HLBBF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
HLBBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
N/A
Address
Ottiliavej 9
Phone
+45 36301311
Employees
5681
Web
https://www.lundbeck.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
MEXX17.670.31
+1.79%
Direxion Dly MSCI Mexico Bull 3X ShsETF
LFAN141.13N/A
N/A
LifeX 2054 Longevity Income ETF
GMOM30.58-0.03
-0.09%
Cambria Global Momentum ETF
RSPG74.64-0.28
-0.37%
Invesco S&P 500® Equal Weight Energy ETF
FLCB21.42-0.14
-0.65%
Franklin U.S. Core Bond ETF

HLBBF and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, HLBBF has been loosely correlated with DRRX. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if HLBBF jumps, then DRRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLBBF
1D Price
Change %
HLBBF100%
N/A
DRRX - HLBBF
38%
Loosely correlated
+0.53%
BNXTF - HLBBF
27%
Poorly correlated
-3.09%
HLUBF - HLBBF
19%
Poorly correlated
N/A
HLNCF - HLBBF
8%
Poorly correlated
+2.77%
HLN - HLBBF
4%
Poorly correlated
+0.09%
More

Groups containing HLBBF

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLBBF
1D Price
Change %
HLBBF100%
N/A
Pharmaceuticals: Generic
industry (228 stocks)
10%
Poorly correlated
-1.77%